KROS
#3579
Keros Therapeutics, Inc. - common stock
11.0 3 USD
+0.04%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+4.35%
Monthly Change
+9.32%
6 month change
-40.83%
Year Change
-26.95%
Previous Close
10.5 7
Open
11.0 3
Low
11.0 3
High
11.0 3
Volume
32
Financials
- Market Capitalization 218.3 M
- Employee 87
- Founded 2015
- CEO N/A
- Website www.kerostx.com
- Headquarter Massachusetts, United States
- FIGI BBG00H1HP9G9
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-4.36
Price to sales ratio
13.69
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3569 |  NAUT Nautilus Biotechnology, Inc. - Common Stock | 1.74 USD | -0.57% | -7.45% | -21.27% | +128.95% | 221.12 M USD | ||
| 3577 |  OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares | 3.65 USD | -1.08% | -6.89% | -6.41% | +15.14% | 218.56 M USD | ||
| 3582 |  KPTI Karyopharm Therapeutics Inc. - Common Stock | 9.53 USD | -4.80% | -11.43% | +3.59% | -1.14% | 215.98 M USD | ||
| 3586 |  SLGL Sol-Gel Technologies Ltd. - Ordinary Shares | 77.22 USD | +2.43% | +2.96% | +8.23% | +809.54% | 215.15 M USD |
Frequently asked questions about Keros Therapeutics, Inc. - common stock
What is the Keros Therapeutics, Inc. - common stock stock price today?
The current price of Keros Therapeutics, Inc. - common stock (KROS) is 11.03. Over the past 24 hours, the stock has changed by +4.35%. Follow the KROS chart for real-time price dynamics.
What is the stock ticker of Keros Therapeutics, Inc. - common stock?
Keros Therapeutics, Inc. - common stock trades under the ticker KROS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Keros Therapeutics, Inc. - common stock stock going up?
KROS has changed by -5.32% over the last week, +9.32% over the last month, and -26.95% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Keros Therapeutics, Inc. - common stock net income for the last quarter?
Keros Therapeutics, Inc. - common stock reported net income of -23.71 M for the last quarter. The previous quarter showed -23.46 M, which means net income changed by -1.05%.
How many employees does Keros Therapeutics, Inc. - common stock have?
As of the latest available data, Keros Therapeutics, Inc. - common stock has 87 employees. Workforce size can provide additional context about the company's scale and operations.
What is Keros Therapeutics, Inc. - common stock EBITDA?
Keros Therapeutics, Inc. - common stock EBITDA is -25.81 M, and its EBITDA margin is -80.65 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Keros Therapeutics, Inc. - common stock stock?
You can buy Keros Therapeutics, Inc. - common stock (KROS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Keros Therapeutics, Inc. - common stock stock?
Investing in Keros Therapeutics, Inc. - common stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the KROS chart and related analysis on metatrader.com as part of your research.